Search Result "IP Drug Therapy"
Intraperitoneal Drug Therapy: An Advantage
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 82-88
Author(s): Kunal Chaudhary, Shadi Haddadin, Ravi Nistala, Chris Papageorgio
Potentialities of Induced Pluripotent Stem (iPS) Cells for Treatment of Diseases
Journal: Current Molecular Medicine
Volume: 10 Issue: 8 Year: 2010 Page: 756-762
Author(s): C. Chakraborty, K. D. Shah, W. G. Caob, C. H. Hsu, Z. H. Wen, C. S. Lin
Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 4 Year: 2011 Page: 449-458
Author(s): L. W. Chen, F. Kuang, L. C. Wei, Y. X. Ding, K. K.L. Yung, Y. S. Chan
Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2010 Page: 759-766
Author(s): I. Gunaseeli, M. X. Doss, C. Antzelevitch, J. Hescheler, A. Sachinidis
Disease-Specific iPS Cell Models in Neuroscience
Journal: Current Molecular Medicine
Volume: 13 Issue: 5 Year: 2013 Page: 832-841
Author(s): M. Peitz, J. Jungverdorben, O. Brustle
Cell Therapy Using Induced Pluripotent Stem (iPS) Cells Meets Next-Next Generation DNA Sequencing Technology
Journal: Current Genomics
Volume: 10 Issue: 5 Year: 2009 Page: 303-305
Author(s): Manabu Nakayama
Cardioprotection by Conditioning Mimetic Drugs
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2016 Page: 15-30
Author(s): Elpidio Santillo, Monica Migale, Demetrio Postacchini, Fabrizio Balestrini, Raffaele Antonelli Incalzi
Social Leverage of Intellectual Property: Road to the Development of Better Therapy for Tuberculosis
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 114-122
Author(s): Harry Thangaraj, Rajko Reljic
Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1184-1191
Author(s): E. Hiltbrand, G. Fournet, J-P. Giliberto, M-J. Paret, J. Chantepie, D. Morel, J. Gore, U. Reichert, H. Mehier, M-E. Rochedix, G. Quash
Ethnicity and Drug Therapy for Hypertension
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 1691-1701
Author(s): K Amudha, Li P Wong, Anna-Maria J Choy, Chim C. Lang